Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Yong Xiao Wang
Keynote Presentation
Yong Xiao Wang, Albany Medical College, United States

Biotherapy in cancer and several other diseases has been rapidly growing. On the other hand,  litter is known about biotherapy in respiratory diseases. One of common and devastating respiratory diseases is asthma. The current medications in asthma are not always effective, o [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Adnan Elfarra
Keynote Presentation
Adnan Elfarra, University of Wisconsin, United States

Glutathione (GSH)-dependent Michael addition-elimination reactions were examined as a strategy to design anticancer prodrugs.  In this regard, methyl vinyl ketone derivatives of 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) were shown to react readily with GSH to yield 6- [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Victoria Demina
Oral Presentation
Victoria Demina, NEUWAY Pharma GmbH, Germany

  The blood brain barrier (BBB) is both a blessing and a curse: On the one hand, the tightly connected endothelial cells covering the cerebral blood vessels protect the brain from harmful large molecules. On the other hand, they are the obstacle to treat severe central ne [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Bhuvanesh baniya
Oral Presentation
Bhuvanesh baniya, Jai Narain Vyas University Jodhpur, India

Human immunodeficiency virus (HIV) infection is now recognized as a chronic illness. An estimated 33 million people are infected with HIV worldwide. With the advent of highly active antiretroviral therapy (HAART), HIV-1 infection is now manageable as a chronic disease in patients [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Haddouchi
Oral Presentation
Haddouchi, Sotax Pharma Services, France

Dissolution is a critical parameter of pharmaceutical dosage forms. It is indeed an extremely powerful tool to acquire knowledge about pharmaceutical products. The dissolution techniques can also be used to learn more about the properties of the Active Pharmaceutical Ingredient ( [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Limce Thampi
Oral Presentation
Limce Thampi, Chemists college of Pharmaceutical Sciences and Research, India

Infectious diseases become a global health problem due to changes of host populations, characters of pathogens and changes in environment. Therefore, the need of developing optimized drug formulations to minimize the drug resistance and to widen the spectrum of antifungal activit [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Madhav Bhatia
Oral Presentation
Madhav Bhatia , University of Otago, New Zealand

Inflammation is a normal adaptive response to traumatic, infectious, post-ischemic, toxic or autoimmune injury. Uncontrolled inflammation, however, results in disease, and most of the diseases have been shown to have an inflammatory component. Identifying biological molecules tha [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Malak Almutairi
Oral Presentation
Malak Almutairi, Saudi Food and Drug Authority, Saudi Arabia

Background: Saudi Food and Drug Authority (SFDA) internal records showed that several pharmaceutical entities are overlapping in their tasks within the system of drug availability in the Saudi market. This may have led to a discrepancy in the awareness and understanding of dru [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Mia Karam
Oral Presentation
Mia Karam, American University of Beirut, Lebanon

Diabetes is a metabolic disorder characterized by hyperglycemia and affecting more than 460 million people worldwide. Uncontrolled diabetes can lead to secondary complications such as non-healing diabetic foot ulcers (DFUs) due to ischemia and peripheral neuropathy. Non-healing D [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Sandeep
Oral Presentation
Sandeep, Jawaharlal Nehru University, India

Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra and presence of intra- cytoplasmic inclusion bodies known as lewy body containing α- synuclein aggregate . [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Mirjana B. Colovic
Oral Presentation
Mirjana B. Colovic, University of Belgrade, Serbia

Acetylcholinesterase is a serine hydrolase whose key biological role is the termination of impulse transmission at cholinergic synapses by rapid hydrolysis of the neurotransmitter acetylcholine. The reversible inhibition of brain acetylcholinesterase is the major therapeutic targ [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Heema Desai
Oral Presentation
Heema Desai, Texila American University, India

International Conference on Harmonization guideline E6 requires clinical trial sponsors to conduct monitoring oversight to ensure protection of rights, safety and welfare of the clinical trial subjects. In 1988, the FDA released a guideline for Monitoring of Clinical Investigatio [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Tanvi S Kabre
Oral Presentation
Tanvi S Kabre, Texila American University, India

A steep rise is seen in conduct of clinically trials not just globally but in India as well over the years. Through this pharma industry is striving to serve high quality treatments and procedure options catering to all class of populations and including those for complex disease [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Violina Kakoty
Oral Presentation
Violina Kakoty, Birla Institute of Technology and Science-Pilani, India

Insulin resistance (IR) and accumulation of amyloid beta (Aβ) oligomers are potential causative factor for Alzheimer Disease (AD). Simultaneously, enhanced clearance level of these oligomers through autophagy activation bring novel insights into their therapeutic paradigm. A [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Bhupendra Gopalbhai Prajapati
Oral Presentation
Bhupendra Gopalbhai Prajapati, Ganpat University, Shree S.K.Patel College of Pharmaceutical Education and Research, India

Self-emulsifying system-based lipstick may prove to have potential of enhancing the moisturizing characteristics and deliver the hydrophobic drug antifungal drugs for the treatment of lip fungal infections. In this study, the self-emulsifying (SEDDs) mixture of Ketoconazole was o [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Ahmed Raza Khan
Oral Presentation
Ahmed Raza Khan, Australian National University, Australia

Local-strain engineering is an exciting approach to tune the optoelectronic properties of materials and enhance the performance of devices. Two dimensional (2D) materials such as 2D transition metal dichalcogenides (TMDCs) are particularly well-suited for this purpose because the [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Divya Sharma
Oral Presentation
Divya Sharma, Delhi Pharmaceutical Sciences and Research University, India

Controlled drug delivery systems release drugs at a pre-set pace in order to maintain a constant drug concentration over a set period of time while minimising side effects. Repaglinide is a low-dose drug that is administered immediately before a meal to lower blood glucose levels [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Sandile Phinda Songca
Oral Presentation
Sandile Phinda Songca, University of KwaZulu-Natal, South Africa

The various mechanisms of sol-gel formulation based on sol-gel phase transitions discussed in this paper share one commonality. The pharmaceutical or novel drug is dissolved in the aqueous solution of the gel followed by initiation of the transition to give a gel formulation in v [....] » Read More

Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Seyed Mohammad Mousavi
Oral Presentation
Seyed Mohammad Mousavi, Tehran University of Medical Sciences, Tehran, Iran., Iran (Islamic Republic of)

There is an increased interest in the potential health benefits of nutraceutical therapies, such as Anethum graveolens (dill). Therefore, this systematic review and meta-analysis aimed to evaluate the effects of Anethum graveolens supplementation on lipid profiles and glycemic in [....] » Read More

Watsapp